These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 38396959)
1. Biomarker Identification through Proteomics in Colorectal Cancer. Martín-García D; García-Aranda M; Redondo M Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396959 [TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer. Ma H; Chen G; Guo M Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366 [TBL] [Abstract][Full Text] [Related]
3. Proteomics for discovery of candidate colorectal cancer biomarkers. Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574 [TBL] [Abstract][Full Text] [Related]
4. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications. de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294 [TBL] [Abstract][Full Text] [Related]
5. Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer. Corbo C; Cevenini A; Salvatore F Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 28019089 [TBL] [Abstract][Full Text] [Related]
6. Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers. Ang CS; Baker MS; Nice EC Methods Enzymol; 2017; 586():247-274. PubMed ID: 28137566 [TBL] [Abstract][Full Text] [Related]
7. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers. Karagiannis GS; Pavlou MP; Saraon P; Musrap N; Xie A; Batruch I; Prassas I; Dimitromanolakis A; Petraki C; Diamandis EP J Proteomics; 2014 May; 103():121-36. PubMed ID: 24681409 [TBL] [Abstract][Full Text] [Related]
8. Biomarker Profile of Colorectal Cancer: Current Findings and Future Perspective. Hoseini SH; Enayati P; Nazari M; Babakhanzadeh E; Rastgoo M; Sohrabi NB J Gastrointest Cancer; 2024 Jun; 55(2):497-510. PubMed ID: 38168859 [TBL] [Abstract][Full Text] [Related]
9. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Han CL; Chen JS; Chan EC; Wu CP; Yu KH; Chen KT; Tsou CC; Tsai CF; Chien CW; Kuo YB; Lin PY; Yu JS; Hsueh C; Chen MC; Chan CC; Chang YS; Chen YJ Mol Cell Proteomics; 2011 Apr; 10(4):M110.003087. PubMed ID: 21209152 [TBL] [Abstract][Full Text] [Related]
10. Proteomics for early detection of colorectal cancer: recent updates. Alnabulsi A; Murray GI Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727 [TBL] [Abstract][Full Text] [Related]
11. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry. Sethi MK; Hancock WS; Fanayan S Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471 [TBL] [Abstract][Full Text] [Related]
12. Moving forward in colorectal cancer research, what proteomics has to tell. Bitarte N; Bandrés E; Zárate R; Ramirez N; Garcia-Foncillas J World J Gastroenterol; 2007 Nov; 13(44):5813-21. PubMed ID: 17990347 [TBL] [Abstract][Full Text] [Related]
13. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development. Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884 [No Abstract] [Full Text] [Related]
14. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759 [TBL] [Abstract][Full Text] [Related]
15. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges. Das V; Kalita J; Pal M Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600 [TBL] [Abstract][Full Text] [Related]
16. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives. Lee PY; Chin SF; Low TY; Jamal R J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962 [TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare? Reumer A; Maes E; Mertens I; Cho WC; Landuyt B; Valkenborg D; Schoofs L; Baggerman G Expert Rev Proteomics; 2014 Aug; 11(4):449-63. PubMed ID: 24702250 [TBL] [Abstract][Full Text] [Related]
18. A large-scale and robust dynamic MRM study of colorectal cancer biomarkers. You J; Kao A; Dillon R; Croner LJ; Benz R; Blume JE; Wilcox B J Proteomics; 2018 Sep; 187():80-92. PubMed ID: 29953963 [TBL] [Abstract][Full Text] [Related]
19. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. Jimenez CR; Knol JC; Meijer GA; Fijneman RJ J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272 [TBL] [Abstract][Full Text] [Related]
20. Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers. Zhu G; Jin L; Sun W; Wang S; Liu N Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188735. PubMed ID: 35577141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]